Indian Paclitaxel Exporters: Complete Supplier Ranking with Market Share — 319 Manufacturers (2026) — TransData Nexus

Q: Who is the largest paclitaxel supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the largest paclitaxel exporter from India with a 30.2% market share and export value of $25.1M.

Q: How many paclitaxel suppliers are there in India?

There are 319 active paclitaxel exporters in India, collectively shipping $83.1M worth of paclitaxel across 4,928 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top paclitaxel suppliers from India?

The top 5 paclitaxel suppliers from India — FRESENIUS KABI ONCOLOGY LIMITED, MSN LABORATORIES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, JODAS EXPOIM PRIVATE LIMITED, PANACEA BIOTEC PHARMA LIMITED — together control 60.7% of total paclitaxel export value from India.

Suresh Sormare

Paclitaxel

India Pharmaceutical Trade Intelligence

$83.1M319 Suppliers142 CountriesHS 30049044

ExportsIndia → GERMANY20.6%India → UNITED STATES13.1%

ImportsSOUTH KOREA → India$1.6B UNITED STATES → India$2.3M

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Paclitaxel Suppliers from India (2026) — 319 Exporters, $83.1M Market | TransData Nexus | TransData Nexus

Who Exports Paclitaxel from India — 319 Suppliers Behind a $83.1M Market

India's paclitaxel export market is supplied by 319 active exporters who collectively shipped $83.1M across 4,928 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 30.2% market share, followed by MSN LABORATORIES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 60.7% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Paclitaxel Suppliers & Exporters — 319 manufacturers, $83.1M export market, top destinations and formulations — Paclitaxel supplier data — 319 exporters · $83.1M market · 4,928 shipmentsTransData Nexus · Indian Customs Data

Top Paclitaxel Exporters from India — Ranked by Export Value

FRESENIUS KABI ONCOLOGY LIMITED is the leading paclitaxel exporter from India, holding a 30.2% share of the $83.1M market across 4,928 shipments from 319 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, MSN LABORATORIES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, JODAS EXPOIM PRIVATE LIMITED, PANACEA BIOTEC PHARMA LIMITED — collectively control 60.7% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (30.2%), MSN LABORATORIES PRIVATE LIMITED (9.3%), INTAS PHARMACEUTICALS LIMITED (7.1%), JODAS EXPOIM PRIVATE LIMITED (7.1%), PANACEA BIOTEC PHARMA LIMITED (6.9%).

Top Paclitaxel Exporters from India

Ranked by export value · 319 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Paclitaxel Exporters from India — Ranked by Export Value. 319 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Paclitaxel — Export Intelligence Video

Visual overview of India's paclitaxel supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's paclitaxel pharmaceutical supplier landscape — $83.1M in total trade, 319 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Paclitaxel exporters

Certification and compliance status for top Paclitaxel suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, December	Yes, April 2007	Yes	Not verified	Received FDA warning letter in December 2022 for data falsification at Sanand fa
Alembic Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant as of July 2025.
Cipla Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant as of February 2024.
Panacea Biotec Pharma Limited	Not Listed	Unknown	No	Not verified	Received EU GMP non-compliance report in February 2026 for Baddi facility.
Venus Remedies Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant.
MSN Laboratories Private Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant.
Fresenius Kabi Oncology Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant.
Jodas Expoim Private Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified; EU-GMP compliant.

TransData Nexus reviewed the regulatory standing of 8 leading Paclitaxel exporters from India. 6 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 7 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Paclitaxel sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Pharma Capital of India," is a pivotal center for bulk drug manufacturing. The city contributes approximately 40% of the country's bulk drug production, earning it the moniker "Bulk Drug Capital of India." This prominence is bolstered by the presence of Genome Valley, a premier biotech cluster housing over 200 life sciences companies, including global giants like Novartis, Bayer, and Sanofi. Hyderabad's robust infrastructure and skilled workforce make it a significant player in the production of active pharmaceutical ingredients (APIs) such as Paclitaxel.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara serving as major pharmaceutical hubs. Vadodara, in particular, is home to Alembic Pharmaceuticals, a leading manufacturer of both APIs and formulations. The region's focus on formulations complements the bulk drug production capabilities of other clusters, contributing to the comprehensive supply chain for drugs like Paclitaxel.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Paclitaxel exporters from India

January 2025

Collaboration

Intas Pharmaceuticals Limited — Intas partners with mAbxience for Etanercept biosimilar

Intas Pharmaceuticals Limited announced a licensing agreement with mAbxience for the Etanercept biosimilar, aiming to expand their biosimilar portfolio and enhance global market reach. - IMPACT: This collaboration may divert resources towards biosimilars, potentially affecting Paclitaxel production and export volumes.

Impact: This collaboration may divert resources towards biosimilars, potentially affecting Paclitaxel production and export volumes.

August 2022

M&A

Fresenius Kabi Oncology Limited — Fresenius Kabi acquires majority stake in mAbxience

Fresenius Kabi acquired a majority stake in mAbxience, enhancing its biologic production capabilities and strengthening its biosimilars pipeline to deliver cost-effective therapies. - IMPACT: The acquisition may lead to a strategic shift towards biosimilars, potentially impacting Paclitaxel export focus.

Impact: The acquisition may lead to a strategic shift towards biosimilars, potentially impacting Paclitaxel export focus.

Common Questions — Paclitaxel Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which paclitaxel supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 854 recorded shipments worth $25.1M. MSN LABORATORIES PRIVATE LIMITED (138 shipments) and INTAS PHARMACEUTICALS LIMITED (405 shipments) are also established high-volume exporters.

Q How many paclitaxel manufacturers are there in India?

India has 319 active paclitaxel exporters with a combined export market of $83.1M across 4,928 shipments to 142 countries. The top 5 suppliers hold 60.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for paclitaxel from India?

Average FOB unit price: $16.32 per unit, ranging from $0.01 to $2799.75. Average shipment value: $16.9K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Paclitaxel

Paclitaxel

Who Exports Paclitaxel from India — 319 Suppliers Behind a $83.1M Market

Top Paclitaxel Exporters from India — Ranked by Export Value

Top Paclitaxel Exporters from India

Related Analysis

Need Details?

Paclitaxel — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Intas Pharmaceuticals Limited — Intas partners with mAbxience for Etanercept biosimilar

Fresenius Kabi Oncology Limited — Fresenius Kabi acquires majority stake in mAbxience

Common Questions — Paclitaxel Suppliers from India

Q Which paclitaxel supplier from India is the most reliable for bulk orders?

Q How many paclitaxel manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for paclitaxel from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Fresenius Kabi Oncology Limited — Fresenius Kabi's Ustekinumab biosimilar approved in EU and US

Analysis Methodology